COMPANY
SimplusDx, Inc.
NIH awards 2
- NIH award 1R01CA310960-01 FY2026: $532,105 awarded for that fiscal year; activity R01 (OTHER_NIH); PI HEGGESTAD, JACOB; recipient as written: SIMPLUSDX, INC., DURHAM, NC. Development and validation of a point-of-need source ↗
- NIH award 1R43TR005794-01 FY2025: $306,299 awarded for that fiscal year; activity R43 (SBIR); PI HEGGESTAD, JACOB; recipient as written: SIMPLUSDX, INC., DURHAM, NC. A rapid point-of-care test for therapeutic drug mo source ↗
Funding and NIH signals
- NIH award NIH awarded $532K (NIH grant 1R01CA310960-01, new, notice Jun 18, 2026). NIH RePORTER 1R01CA310960-01 (Jun 18, 2026)
Evidence (1 event)
- Jun 18, 2026 · NIH RePORTER 1R01CA310960-01
Organization: SIMPLUSDX, INC.; City/State: DURHAM, NC; Project number: 1R01CA310960-01; Activity code: R01; Fiscal year: 2026; Award notice date: 2026-06-18; FY total cost (award amount): 532105; Administering IC: National Cancer Institute; Project title: Development and validation of a point-of-need screening test for hepatocellular carcinoma; Organization type: Domestic For-Profits
- Jun 18, 2026 · NIH RePORTER 1R01CA310960-01